• Latest Posts

Molecure raises $12M and gets FDA clearance for pulmonary sarcoidosis trial

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

Crescendo Biologics raises $32M and expands cancer trial

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

Endometrial cancer drug receives breakthrough therapy designation in China 

Mage Biologics created to develop oral antibody therapy for ulcerative colitis


Seven pharma companies form alliance to prepare for future pandemics 

Biomica announces interim positive results from irritable bowel syndrome program

Sosei Heptares hails ‘transformational’ acquisition

Novel bacterial communication system could help take on antimicrobial resistance

Moleculin issues acute myeloid leukemia drug data

Korro Bio and Frequency Therapeutics to merge